Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
NCT03508271 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60000
Last updated 2019-01-04
Summary
Observational study of elderly individuals diagnosed with Non-Valvular Atrial Fibrillation and Heart Failure who are beginning oral blood thinners
Conditions
Interventions
- OTHER
-
Non-Interventional
Non-Interventional
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-30
- Primary Completion
- 2018-11-08
- Completion
- 2018-11-08
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare
NCT04681482 ·Status: COMPLETED
-
This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain
NCT03285373 ·Status: COMPLETED
-
Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
NCT04684056 ·Status: UNKNOWN
-
Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
NCT06108414 ·Status: RECRUITING ·Phase: PHASE4
-
A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF
NCT04907825 ·Status: COMPLETED ·Phase: PHASE4
-
This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain
NCT03993119 ·Status: COMPLETED
-
Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)
NCT00568594 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients
NCT04128878 ·Status: COMPLETED
-
Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure
NCT01055912 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure
NCT01120210 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty
NCT04743063 ·Status: UNKNOWN
-
Clinical Decision Support Tool for Improving the Adequacy of Anticoagulant Therapy in Non-valvular Atrial Fibrillation
NCT03367325 ·Status: UNKNOWN ·Phase: NA
-
DOAC in Chinese Patients With Atrial Fibrillation
NCT05378035 ·Status: RECRUITING
-
Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation
NCT05320627 ·Status: COMPLETED ·Phase: PHASE4
-
Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion
NCT04195997 ·Status: UNKNOWN ·Phase: PHASE4
-
Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation
NCT05039359 ·Status: TERMINATED ·Phase: PHASE3
-
Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction
NCT02262078 ·Status: COMPLETED ·Phase: PHASE2
-
Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation
NCT02623049 ·Status: UNKNOWN
-
A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data
NCT05096143 ·Status: COMPLETED
-
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
NCT00526136 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation
NCT02832089 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
NCT07218627 ·Status: RECRUITING ·Phase: PHASE1
-
Elaboration of a Prioritization Score for Pharmaceutical Interviews in Patients Treated With Oral Anticoagulants
NCT06100380 ·Status: COMPLETED
-
Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation
NCT05991284 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Phase 2 Study of Oral K201 for Prevention of AF Recurrence
NCT01067833 ·Status: TERMINATED ·Phase: PHASE2